Latest available resultsQuarter ended June 30, 202610-Q · July 21, 2026
Filed with the SEC3M CO
MMMHealthcare
Next reportOctober 19, 2026Analyst forecast 2.417 $/share
Revenue
$6.50B
▲ +2.5% vs prior year% YoY
Net income
$933.00M
▲ +29.0% vs prior year% YoY
EPS
1.78$
▲ +32.8% vs prior year% YoY
Net margin
14.4%
▲ +3.0 percentage points vs prior year pp YoY
Revenue▲ +2.5 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +29.0 %
EPS▲ +32.8 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $6.50B | |
| Gross profit | $2.68B | 41.3 % |
| Operating income | $984.00M | 15.1 % |
| Net income | $933.00M | 14.4 % |
| R&D | — | |
| EPS (diluted) | 1.78 $ | |
| Balance sheet | ||
| Assets | $34.92B | |
| Liabilities | $31.92B | |
| Equity | $3.00B | |
| Cash | — | |
| Capital | ||
| Shares outstanding | 515.72M | as of 2026-06-30 |
| Public float | — | |